Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

To see complete record on, please visit this link

Id: NCT05037123

Organisation Name: NYU Langone Health

Overal Status: Not yet recruiting

Start Date: October 1, 2021

Last Update: September 8, 2021

Lead Sponsor: NYU Langone Health

Brief Summary: Our study utilizes a 3-arm placebo-controlled RCT to study the effectiveness of ketamine in reducing chronic post-mastectomy pain. Participants randomized to the first arm will receive a 0.35 mg/kg dose after induction, followed by a 0.3 mg/kg/hr infusion throughout surgery and continued for 2 hours postoperatively. Participants in the second arm will receive a single dose of 0.6 mg/kg of ketamine in the post-anesthesia care unit, and the final group will serve as the control group and receive saline (no ketamine).

  • Chronic Postsurgical Pain

Total execution time in seconds: 0.63028502464294